DOAC Cuts Stroke Risk From Subclinical Afib
(MedPage Today) -- PHILADELPHIA -- For patients with subclinical atrial fibrillation (Afib, AF) detected by their pacemaker or defibrillator, direct oral anticoagulation brought their already low stroke risk even lower -- but at a cost in bleeding... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 13, 2023 Category: Cardiology Source Type: news
Dropping Aspirin Cuts Bleeding in LVAD Patients Dropping Aspirin Cuts Bleeding in LVAD Patients
A randomized trial evaluating vitamin K therapy with aspirin or placebo with a left ventricular assist device shows avoiding aspirin reduced bleeding without increasing thrombotic risk.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - November 13, 2023 Category: Transplant Surgery Tags: Cardiology News Source Type: news
Dropping Aspirin Cuts Bleeding in LVAD Patients Dropping Aspirin Cuts Bleeding in LVAD Patients
A randomized trial evaluating vitamin K therapy with aspirin or placebo with a left ventricular assist device shows avoiding aspirin reduced bleeding without increasing thrombotic risk.MDedge News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - November 13, 2023 Category: Internal Medicine Tags: Cardiology News Source Type: news
TIMI Study Finds New Class of Anti-Clotting Drug Reduced Bleeding Events Compared with Standard of Care in Patients with Atrial Fibrillation
The researchers found that abelacimab, a Factor XI inhibitor, at a dose of 150 mg monthly, significantly reduced bleeding compared to the standard-of-care anticoagulant, rivaroxaban. (Source: BWH News)
Source: BWH News - November 13, 2023 Category: Hospital Management Source Type: news
Apixaban Cuts Stroke But Ups Bleeding in Subclinical AF Apixaban Cuts Stroke But Ups Bleeding in Subclinical AF
Further analyses from the ARTESIA study and the previous NOAH-AFNET 6 trial are needed to try to identify groups where the benefit may outweigh the risk, researchers say.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 12, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
What will the NHS do about its dire sexism problem? As BBC presenter Naga Munchetty tells MPs about her appalling treatment, readers share their own harrowing stories
It was more than three decades ago that doctors first told Naga Munchetty , then a teenager, that the heavy bleeding and pain she endured for nine days of every month was normal. (Source: the Mail online | Health)
Source: the Mail online | Health - November 11, 2023 Category: Consumer Health News Source Type: news
DeSantis' Disney district is bleeding employees, exit surveys reveal, as poor morale and cronyism leave it'no longer functional '
Morale and trust within the Walt Disney World government has deteriorated since allies of Florida Gov. Ron DeSantis took it over earlier this year, according to many employees who have departed in recent months saying the governing district has been politicized and cronyism now permeates the…#waltdisneyworld #florida #rondesantis #seekingrents #floridalegislature #disney #desantis #matthewoberly #martingarcia #glengilzean (Source: Reuters: Health)
Source: Reuters: Health - November 6, 2023 Category: Consumer Health News Source Type: news
Mayo Clinic Minute: Nonsurgical treatment for uterine fibroids
Uterine fibroids are the leading cause of women undergoing hysterectomies, leaving them unable to bear children. Fibroids often are diagnosed in women between 20 and 40. They can cause heavy menstrual bleeding, pain and infertility. Dr. Michelle Louie, a Mayo Clinic gynecologic surgeon and fibroid specialist, says there's a newer nonsurgical procedure to remove fibroids. Watch: The Mayo Clinic Minute https://youtu.be/59C6mvXPF7I Journalists: Broadcast-quality video (1:04) is in the downloads at the end of the post.… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 6, 2023 Category: Databases & Libraries Source Type: news
Thalidomide Cuts Recurrent Bleeding in Small-Intestinal Angiodysplasia
THURSDAY, Nov. 2, 2023 -- For patients with recurrent bleeding due to small-intestinal angiodysplasia (SIA), thalidomide treatment results in a reduction in bleeding, according to a study published in the Nov. 2 issue of the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 2, 2023 Category: Pharmaceuticals Source Type: news
Thalidomide Reduced Episodes of Recurrent GI Bleeding
(MedPage Today) -- Treatment with thalidomide led to a reduction in bleeding among patients with recurrent bleeding due to small-intestinal angiodysplasia (SIA), a randomized trial showed.
In 150 patients, 68.6% of those who received 100-mg thalidomide... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 2, 2023 Category: Gastroenterology Source Type: news
' Very worrying': Bleeding virus found for the first time in ticks in France. Here ’s what we know
French authorities said that Crimean-Congo haemorrhagic fever (CCHF) was detected in ticks in southern France this month. Climate change favours their further spread, experts say.#crimean #congo #cchf (Source: Reuters: Health)
Source: Reuters: Health - November 1, 2023 Category: Consumer Health News Source Type: news
Africa: Cervical Cancer Survivors Demand Equity and Unity
[allAfrica] Gaborone -- When Karen Nakawala-Mayond experienced a nagging backache she put it down to her love for high heels. And then when she started bleeding in between her monthly periods, she thought it was the onset of menopause. That was until her gynaecologist insisted that she be screened for cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 30, 2023 Category: African Health Tags: Africa Botswana Health and Medicine Noncommunicable Diseases Southern Africa Sustainable Development Zambia Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] FDA approves Roche ’s Vabysmo for the treatment of retinal vein occlusion (RVO)
RVO is the third indication for Vabysmo, in addition to neovascular or ‘wet’ age-related macular degeneration and diabetic macular edemaApproval is based on two phase III studies demonstrating early and sustained vision improvements that were non-inferior to afliberceptVabysmo also demonstrated rapid and robust drying of retinal fluidAdditional U.S. label update across indications includes information on rare post-marketing reports of retinal vasculitis and/or retinal vascular occlusion; reporting rate isin line withother broadly used intravitreal treatmentsBasel, 27 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) an...
Source: Roche Investor Update - October 27, 2023 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] FDA approves Roche ’s Vabysmo for the treatment of retinal vein occlusion (RVO)
RVO is the third indication for Vabysmo, in addition to neovascular or ‘wet’ age-related macular degeneration and diabetic macular edemaApproval is based on two phase III studies demonstrating early and sustained vision improvements that were non-inferior to afliberceptVabysmo also demonstrated rapid and robust drying of retinal fluidAdditional U.S. label update across indications includes information on rare post-marketing reports of retinal vasculitis and/or retinal vascular occlusion; reporting rate isin line withother broadly used intravitreal treatmentsBasel, 27 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) an...
Source: Roche Media News - October 27, 2023 Category: Pharmaceuticals Source Type: news
Killer 'eye-bleeding' virus is found in FRANCE for first time amid fears tick-borne disease will soon make Britain home
French health authorities have confirmed they have ticks carrying Crimean-Congo haemorrhagic fever, a virus that kills up to 40 per cent of people it infects, in the country for the first time. (Source: the Mail online | Health)
Source: the Mail online | Health - October 26, 2023 Category: Consumer Health News Source Type: news
